Abstract
Sera of COVID-19 naive vaccinees, COVID-19 recovered cases with vaccination and breakthrough cases demonstrated 1.3, 2.5 and 1.9-fold reduction in neutralization titers against Delta and 1.5, 3.5, 2.8-fold against Delta AY.1 compared to B.1 respectively. However, high neutralization titers would still effectively protect against Delta, Delta AY.1 and B.1.617.3 variants.
Keywords: BBV152; Delta; Delta AY.1; SARS-CoV-2; neutralization; variant of concern.
All Keywords
【저자키워드】 SARS-CoV-2, neutralization, Delta, variant of concern, BBV152, Delta AY.1, 【초록키워드】 COVID-19, vaccination, neutralization, variant, variants, sera, neutralization titers, AY.1, B.1, fold, vaccinees, neutralization titer, PROTECT, demonstrated, reduction in, 【제목키워드】 individual,
【저자키워드】 SARS-CoV-2, neutralization, Delta, variant of concern, BBV152, Delta AY.1, 【초록키워드】 COVID-19, vaccination, neutralization, variant, variants, sera, neutralization titers, AY.1, B.1, fold, vaccinees, neutralization titer, PROTECT, demonstrated, reduction in, 【제목키워드】 individual,
{{{ 추상적인 }}}
COVID-19 순진한 백신 접종자, COVID-19 백신 접종으로 회복된 사례 및 돌파구 사례는 B.1에 비해 Delta에 대한 중화 역가에서 1.3, 2.5 및 1.9배 감소 및 Delta AY.1에 대해 1.5, 3.5, 2.8배 감소를 입증했습니다. 각기. 그러나 높은 중화 역가는 Delta, Delta AY.1 및 B.1.617.3 변종에 대해 여전히 효과적으로 보호합니다.
{{ 키워드: }} BBV152; 델타; 델타 AY.1; 사스 코로나바이러스 2; 중립화; 우려의 변형.